Public Release: 

Are the benefits of breast milk stimulant worth the risk?

SAGE

Los Angeles, CA (Nov 4, 2014) Most women can make all the milk their baby needs, but some mothers turn to medications to help increase their supply. While some specialists encourage the off-label use of domperidone to stimulate breast milk production, some studies have suggested it may be related to negative side effects, including irregular heartbeat and sudden cardiac death. In a new article out today, researchers concluded that although domperidone can increase breast milk production, and there is no known risk to the babies who drink the milk, risks to women are still worrying. This review article was published today in Journal of Human Lactation, a SAGE journal.

In order to assess the efficiency and safety of domperidone, researchers Catherine Paul et al. analyzed both the limited studies available on maternal and infant exposure to the stimulant as well as larger studies focused on its use in gastrointestinal disorder treatment. The researchers found the following for those exposed to the drug:

  • No adverse effects were observed in a limited sample of 85 infants and 60 treated mothers

  • Breast milk production moderately improved after 3 daily dosages of 10-20 mg; however some institutions suggest doses as high as 120 or 160 mg.

  • It increased the odds ratio for sudden cardiac death inpatients using more than 30 mg daily

As some women are highly susceptible to certain heart diseases, the researchers claimed the use of domperidone was especially worrisome: "In these circumstances, an improvement of breastfeeding practices seems to be more effective and safer than the use of an off-label domperidone treatment."

###

Find out more by reading the article, "Use of Domperidone as a Galactagogue Drug: A Systematic Review of the Benefit-Risk Ratio," in the Journal of Human Lactation. For an embargoed copy of the article, please email camille.gamboa@sagepub.com.

Journal of Human Lactation (JHL) is a quarterly, peer-reviewed journal publishing original research, commentaries relating to human lactation and breastfeeding behavior, case reports relevant to the practicing lactation consultant and other health professionals who assist lactating mothers or their breastfeeding infants, debate on research methods for breastfeeding and lactation studies, and discussions of the business aspects of lactation consulting. http://jhl.sagepub.com/

Impact Factor: 1.638 | Ranking:12/106 in Nursing | 41/77 in Obstetrics & Gynecology | 49/121 in Pediatrics

Source: 2012 Journal Citation Reports® (Thomson Reuters, 2013)

SAGE is a leading international publisher of journals, books, and digital media for academic, educational, and professional markets. Since 1965, SAGE has helped inform and educate a global community of scholars, practitioners, researchers, and students spanning a wide range of subject areas including business, humanities, social sciences, and science, technology, and medicine. An independent company, SAGE has principal offices in Los Angeles, London, New Delhi, Singapore and Washington DC.

http://www.sagepublications.com

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.